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The influence of the
host microbiome on 3,4methylenedioxymethamphetamine
(MDMA)-induced hyperthermia and
vice versa
Emily A. Ridge1, Sudhan Pachhain2, Sayantan Roy Choudhury2, Sara R. Bodnar1,
Ray A. Larsen2, Vipaporn Phuntumart2 & Jon E. Sprague1
Hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) can be life-threatening.
Here, we investigate the role of the gut microbiome and TGR5 bile acid receptors in MDMA-mediated
hyperthermia. Fourteen days prior to treatment with MDMA, male Sprague-Dawley rats were provided
water or water treated with antibiotics. Animals that had received antibiotics displayed a reduction
in gut bacteria and an attenuated hyperthermic response to MDMA. MDMA treated animals showed
increased uncoupling protein 1 (UCP1) and TGR5 expression levels in brown adipose tissue and skeletal
muscle while increased expression of UCP3 was observed only in skeletal muscle. Antibiotics prior
to MDMA administration significantly blunted these increases in gene expression. Furthermore,
inhibition of the TGR5 receptor with triamterene or of deiodinase II downstream of the TGR5 receptor
with iopanoic acid also resulted in the attenuation of MDMA-induced hyperthermia. MDMA-treatment
enriched the relative proportion of a Proteus mirabilis strain in the ceca of animals not pre-treated
with antibiotics. These findings suggest a contributing role for the gut microbiota in MDMA-mediated
hyperthermia and that MDMA treatment can trigger a rapid remodeling of the composition of the gut
microbiome.
3,4-Methylenedioxymethamphetamine (MDMA) is a synthetic sympathomimetic agent more commonly
known as “Ecstasy” or “Molly.” MDMA induction of hyperthermia involves both central and peripheral triggers.
Centrally, MDMA results in the activation of dopaminergic1 and serotonergic2 receptors in thermoregulatory
circuits in the hypothalamus3–5; ultimately activating peripheral mediators of heat generation. In the periphery,
MDMA-mediated increases in norepinephrine binding to the α1-adrenergeric receptor in vascular smooth muscle, results in vasoconstriction and attenuated heat dissipation6,7. MDMA-induced norepinephrine release also
triggers thermogenesis8 by two routes; each mediated by signaling through β-adrenergic receptors in brown and
white adipose tissue. Norepinephrine mediated activation of β-adrenergic receptor increases the expression of
the UCP1 gene, leading to the production of the uncoupling protein UCP19. β-adrenergic receptor activation
further induces lipolysis, with the resultant release of free fatty acids (FFA) from brown adipose tissue (BAT)
and white adipose tissue (WAT) with subsequent transport of FFA into skeletal muscle mitochondria to serve as
ligand activators for UCP-facilitated proton leak10,11. When activated, UCPs dissipate the proton gradient across
the inner mitochondrial membrane, resulting in increased proton conductance and the release of energy as heat12.
BAT-mediated thermogenesis is an important component in mammalian thermal homeostasis. Dependent
upon stored metabolic fuels, BAT-mediated thermogenesis is modulated by a variety of signals reflecting the metabolic and stored fuel status of the organism13. Bile acids provide one such signal, increasing energy expenditure
in a UCP-dependent fashion in BAT and skeletal muscle14. Using the G-protein coupled receptor TGR5, bile acids
stimulate the production of cyclic AMP, inducing 2-iodothyronine deiodinase (D2) to convert local thyroxine
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Figure 1. Daily fluid intake for both antibiotic-treated (ABX) and control (H2O) groups (A). Mean body weight
for both antibiotic-treated and control groups (B). * indicates significantly different from all other treatment
groups (p = 0.0019). Each value is the mean ± SEM (n = 12).

(T4) into 3,5,3-tri-iodothyronine (T3). T3 in turn stimulates glucose metabolism and lipolysis, fueling thermogenesis15. Binding of bile acids to TGR5 in intestinal cells stimulates the production of glucagon-like peptide 1
(GLP1)16, an insulinotropic hormone that stimulates BAT thermogenesis17.
Bile acids are produced by hepatocytes and secreted into the duodenum where they function in the absorption
of lipids and lipid soluble molecules. The intestinal microbiome actively modulates the size and composition of
the bile acid pool18. The farnesoid X receptor (FXR) provides for negative feedback regulation of bile acid synthesis19. Tauro-conjugated muricholic acids act as FXR antagonists, limiting hepatic bile acid synthesis under normal
conditions; however, in germ-free20 or antibiotic treated mice21, tauro-conjugates are not modified by microbial
activity, resulting in a much larger bile acid pool, indicating that alterations in gut microbiome can alter bile
acid composition22. Interestingly, mice undergo dramatic remodeling of their gut microbiota when adapting to
cold temperatures with accompanying changes in BAT tissue and browning of white adipose tissue. These tissue
changes were transferable with microbiota transplantation into germ-free mice23. Based on these studies and previous knowledge of UCP regulation of MDMA-induced hyperthermia, we hypothesized that the actions of some
members of the intestinal microbiota might influence the sympathomimetic-induced thermogenic response to
MDMA. Because of the role of bile acids in UCP regulation and role of the intestinal microbiome in regulating
the size and composition of the bile acid pool18, we further tested the role of the TGR5 receptor24 and D225 in
MDMA-mediated hyperthermia through their inhibition with triamterene and iopanoic acid respectively. The
results of this study support this hypothesis and further suggests that MDMA can in turn trigger a rapid remodeling of the microbiota composition in at least some intestinal compartments.

Results

Quantification of Intestinal Bacteria by qPCR.

To determine if changes in intestinal microbiota influence the thermogenic response to MDMA, animals were provided a cocktail of antibiotics (ABX): bacitracin,
neomycin, and vancomycin, via their drinking water, for 14 days before MDMA treatment. With the exception of
the first day of exposure to the antibiotics (Fig. 1A- two-tailed t-test: p = 0.0019; t = 3.535), daily fluid intake and
body weight (Fig. 1B- two-tailed t-test: p = 0.2144; t = 1.278) did not differ between groups over the course of the
experiment. To ensure the ability of mixed ABX in reducing gut bacteria, total DNA was purified from 200 mg of
the cecum of each animal and they were pooled together, followed by qPCR analysis using 200 ng of pooled DNA
and universal primers specific for the bacterial 16S rRNA gene. Based on the quantification cycles (Cq) values, a
significant reduction in apparent bacterial number was evident in the ABX groups compared to the H2O control
groups (Fig. 2- two-tailed t-test: p = 0.0016; t = 4.296). Prolonged treatment with antibiotics resulted in markedly
enlarged ceca (data not shown), similar to the previous observations of others26.

Analysis of Cultivatable Cecal Bacteria. qPCR analysis (Fig. 2) established that ABX treatment
reduced bacterial numbers in the cecum relative to untreated controls, evident by the increased Cq value for the
ABX-treated animals (Fig. 2). Our working assumption was that ABX treatment would alter the composition
of the cecal microbiota by differentially selecting against antibiotic sensitive bacterial strains. To determine if
this occurred, we evaluated kanamycin resistance in cecal samples harvested at necropsy from each of the four
groups. Resistance to kanamycin would be indicative of the selection of strains capable of producing aminoglycoside modifying enzymes by the ABX regimen. Comparison of the relative proportions of kanamycin resistant
culturable bacterial verified that such alterations did occur. For the six saline-challenged animals that received
no antibiotics (H2O control), only 15–48% (mean = 27%) of the culturable cecal bacteria grew in the presence of
kanamycin, whereas for the six saline-challenged ABX treated animals (ABX control) 53–100% (mean = 78%) of
the culturable cecal bacteria grew in the presence of kanamycin. A similar proportion of culturable cecal bacteria
(46–83%; mean = 64%) able to grow in the presence of kanamycin were found in the six MDMA-challenged ABX
treated animals (Fig. 3-One way ANOVA with Student-Newman-Keuls post hoc test: F(2,15) = 12.823, p = 0.006).
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Figure 2. Quantification of cecal bacteria by qPCR. Quantification cycles (Cq) values of the 16S rRNA gene
using 200 ng of a pool of DNA extracted from twelve animals per treatment. All qPCR assays were run in
triplicate including no template negative controls. * indicates significant difference between treatment groups
(p = 0.0016). Each value is the mean ± SEM (n = 12).

Figure 3. Relative proportions of kanamycin-tolerant culturable bacteria recovered in cecal contents. * indicates
significantly different from H2O control group (p = 0.006) Each value is the mean ± SEM (n = 6).

For the six non-ABX-treated MDMA-challenged animals (H2O MDMA), the proportion of kanamycin-resistant
culturable bacteria could not be determined, as the colonies were obscured by the presence of swarming bacteria
on plates lacking kanamycin. Bacterial swarming on a nutrient-rich medium is a phenotype associated with the
genus Proteus, a common inhabitant of mammalian digestive systems27. The swarmers were subsequently isolated
as single colonies on MacConkey agar, which contains bile salts that inhibit swarming behavior. Colony PCR of
eight such isolates using primers specific for 16S rRNA produced amplimers corresponding with a sequence to
a 314-base pair region of the 16S rRNA genes (GeneBank accession number MK033607) that is shared by both
Proteus mirabilis and certain isolates of Salmonella enterica, including a serovar Typhimurium strain, all with 100%
sequence identity and minimum E-values of 2.30 E−158 (Fig. 4A). Isolates were compared with a well-documented
strain of S. enterica serovar Typhimurium (ATCC 19585) by plating on another bile salt-containing medium,
Hektoen enteric (HE) agar, that distinguishes salmonella from other enteric bacteria based on the production of
hydrogen sulfide, as visualized by the formation of black ferric sulfate precipitates in the inner region of the colony.
Such precipitates were not evident in swarmer isolates grown on HE agar, but were apparent for the S. enterica
strain (Fig. 4B). Swarmer isolates were re-plated onto a nutrient rich medium (LB) where swarmer behavior was
again evident, in contrast to S. enterica, which did not swarm (Fig. 4C). Collectively, these data suggest that the
swarming bacteria are Proteus mirabilis.

Effects of Gut Microbiota on MDMA-Induced Hyperthermia. MDMA significantly increased core
body temperature in both the antibiotic (ABX) and water (H2O) experimental groups at the 30- and 60-minute
time points as compared to control groups (Fig. 5A-One way ANOVA with Dunnett’s post hoc: F(2,15) = 65.14,
p < 0.0001). The ABX MDMA group showed an attenuated thermogenic response compared to that of the
H2O MDMA group (Fig. 5A-One way ANOVA with Student-Newman-Keuls post hoc between time points:
F(3,20) = 177.35, p < 0.0001). Calculation of the temperature area under the curve (TAUC) provided additional
evidence for the diminished thermogenic responses of the ABX MDMA group relative to that of the H2O MDMA
group (Fig. 5B- two-tailed t-test: p = 0.0043; t = 3.67). ABX pretreatment before MDMA significantly attenuated
the maximal change in core temperature (Fig. 5C- two-tailed t-test: p = 0.006; t = 3.47). To exclude the possibility
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Figure 4. Identification of swarming bacteria. (A) Consensus sequence representing eight swarmer isolates,
corresponding and identical to bases 458–772 of rRNA gene of P. mirabilis AR_0029 (Genebank CPO29725)
and numerous other isolates and S. enterica serovar Typhimurium (Genebank MH356711). (B) Comparison of
swarmer isolate and S. enterica serovar Typhimurium grown on Hektoen enteric agar for 18 hrs at 37 °C. Scale
is indicated by the 1 cm bar at the lower right of the figure. (C) Comparison of swarmer isolate and S. enterica
serovar Typhimurium grown on LB agar for 18 hrs at 37 °C. Contrast in this image was increased to enhance
visualization of the swarming pattern. Scale is indicated by the 1 cm bar at the lower right of the figure.

that the effects of the oral antibiotic treatment on MDMA-induced hyperthermia were due to pharmacodynamic
interactions between MDMA and the antibiotics, a second experiment was performed, with animals injected with
a single intraperitoneal dose of antibiotics (1.67 mg/kg vancomycin, 20 mg/kg neomycin, and 293 U/kg bacitracin
in PBS) thirty minutes prior to treatment with MDMA. These animals did not display an attenuated thermogenic
response to MDMA. Instead, these animals displayed a similar maximum change in temperature as the control
group (data not shown- two-tailed t-test: p = 0.4525; t = 0.781), supporting the interpretation that components
of the microbiota, not the antibiotics, were responsible for the attenuated thermogenic response to MDMA in the
ABX MDMA group.

MDMA Treatment Results in Alteration of the Expression of Genes Associated with Hyperthermia.

To assess the molecular mechanisms underpinning MDMA-mediated hyperthermia, expression of UCP1, UCP3
and TGR5 was examined in BAT and skeletal muscle by qRT-PCR. Results were normalized to β-actin. In BAT,
MDMA treatment showed elevated expression of UCP1 (Fig. 6A-One way ANOVA with Student-Newman-Keuls
post hoc test: F(3,8) = 849.93, p = 0.0001) and TGR5 (Fig. 6A-One way ANOVA with Student-Newman-Keuls
post hoc test: F(3,8) = 2373, p = 0.0001) while the expression of UCP3 was reduced compared to controls
(Fig. 6A-One way ANOVA with Student-Newman-Keuls post hoc test: F(3,8) = 339.12, p = 0.0001). In skeletal
muscle, MDMA increased the expression of UCP1 (Fig. 6B-One way ANOVA with Student-Newman-Keuls
post hoc test: F(2,5) = 3857, p = 0.0001), UCP3 (Fig. 6B-One way ANOVA with Student-Newman-Keuls post hoc
test: F(3,8) = 10872, p = 0.0001) and TGR5 (Fig. 6B-One way ANOVA with Student-Newman-Keuls post hoc test:
F(3,8) = 2696, p = 0.0001). Treatment with ABX for 14 days prior to MDMA challenge down-regulated the expression of these genes in both BAT and skeletal muscle compared to H2O MDMA group.

Effect of triamterene (TM) on MDMA-induced hyperthermia.

In both the vehicle (VEH)/MDMA
and TM/MDMA groups, MDMA administration resulted in a significantly higher core body temperature than
the other treatment groups at the 90-minute time point (Fig. 7A-One way ANOVA with Student-Newman-Keuls
post hoc between time points: F(3,19) = 64.05, p = 0.0001). Animals treated with TM 30 minutes prior to MDMA
demonstrated an attenuated thermogenic response when compared to the VEH/MDMA group (Fig. 7A-One way
ANOVA with Student-Newman-Keuls post hoc between time points: F(3,18) = 23.34, p = 0.0001). TAUC analysis
for the VEH/MDMA group was significantly greater compared to the TM/MDMA group (Fig. 7B- two-tailed
t-test: p = 0.04; t = 2.43). MDMA induced a hyperthermic response that resulted in a maximal temperature
change (ΔTmax) of 3.7 ± 0.2 °C, while TM treatment prior to MDMA attenuated the hyperthermic response
with a ΔTmax of 2.2 ± 0.4 °C (Fig. 7C- two-tailed t-test: p = 0.0045; t = 3.763).

Effect of iopanoic acid (IOP) on MDMA-induced hyperthermia.

In both the VEH/MDMA and
IOP/MDMA groups, MDMA administration resulted in a significantly higher core body temperature than the
other treatment groups at both the 60- and 90-minute time points. Additionally, pretreatment with IOP significantly attenuated MDMA-induced hyperthermia at the 60- and 90-minute time points when compared to the
VEH/MDMA group (Fig. 8A-One way ANOVA with Student-Newman-Keuls post hoc between time points:
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Figure 5. Changes in core temperature following the administration of MDMA (A). Temperature-area under
the curve (TAUC) following the administration of MDMA (B). Maximum change in temperature following the
administration of MDMA (C). * indicates significant difference from all other treatment groups (p < 0.05).
F(3,20) = 64.67, p = 0.0001). Furthermore, the TAUC for VEH/MDMA was significantly greater than IOP/MDMA
(Fig. 8B- two-tailed t-test: p = 0.005; t = 3.562). Finally, the IOP/MDMA treatment resulted in a ΔTmax of
2.1 ± 0.2 °C, which was significantly less than that of VEH/MDMA ΔTmax of 3.7 ± 0.5 (Fig. 8C- two-tailed t-test:
p = 0.0005; t = 5.072).

Discussion

Several studies have found that microbiome-generated heat contributes to the maintenance of body temperature
in animals (for a review see28). Oral treatment of rabbits29 and rodents30,31 with non-absorbable antibiotics lowers core body temperature. Recent findings using Brandt’s voles suggest that changes in core body temperature
changes the host gut microbial community, which in turn regulates the host’s thermal homeostasis32. The present
findings suggest that the microbiome-gut-brain axis may play a contributory role in the hyperthermia mediated
by MDMA. ABX treatment for 14 days prior to MDMA treatment not only reduced the number and altered
the composition of the cecal bacterial population, but also attenuated MDMA-induced hyperthermia. Recently,
Althobailti et al.33, demonstrated that the β-lactam antibiotic, ceftriaxone, administered for three days following methamphetamine treatment blocked the methamphetamine-induced hyperthermia. Those authors did not
examine the effects of ceftriaxone treatment on the gut microbiome, but linked the effects to ceftriaxone regulation of the central expression of the glutamate transporter. Intraperitoneal injection of minocycline for three
days has been shown to attenuate the hyperthermic effects of MDMA34, but had no effect on body temperature
when given for two days35. Previous studies by Rawls et al.36 found that ceftriaxone given for seven days prior to
hyperthermic doses of morphine also blocked hyperthermia. They suggested a potential role for the glutamate
transporter, but did not examine the effects of ceftriaxone on the gut microbiome. This present study is the first
to examine the potential role of the bacterial component of the gut microbiome in the hyperthermia associated
with drugs of abuse. Although the results of the present study demonstrate a potential relationship between
MDMA-induced hyperthermia and the gut microbiome, they do not suggest that the microbiome is a major contributor to this hyperthermia in that the effects of the ABX treatment were slight yet significant.
We have recently ascertained that UCP1 and UCP3 play complementary roles in the onset (UCP1) and maintenance (UCP3) of sympathomimetic-induced hyperthermia37. In the present study, we observed an increase in
UCP1 expression in both BAT and skeletal muscle following MDMA challenge while UCP3 expression increased
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Figure 6. qPCR gene expression analysis of TGR5, UCP1 and UCP3 in (A) BAT and (B) skeletal muscle.
* significantly different from all other treatment groups (p < 0.01). ** significantly different from all other
treatment groups (p < 0.001). Each value is the mean ± SEM (n = 6).

only in skeletal muscle. ABX treatment blocked these changes in UCP expression levels, consistent with our
previous studies regarding the role of UCP in MDMA-mediated hyperthermia37. The TGR5 receptor has been
suggested to play a role in cold-induced thermogenesis through its regulation of the thyroid-catalyst protein
deiodinase II (D2) and the ultimate regulation of UCP expression14,38. Similarly, in both BAT and skeletal muscle
of our rat models, MDMA increased TGR5 expression levels. Conversely, prior ABX treatment rendered TGR5
gene expression refractory to this MDMA-induced change.
Recent studies have suggested that TM inhibits the TGR5 receptor24. Those authors reported that TM was able
to dose-dependently inhibit the increase in glucose uptake mediated by TGR5 agonists in Chinese hamster ovary
cells (CHO-K1 cells). Moreover, glucagon-like peptide-1 secretion and increased cAMP levels, which are induced
by TGR5 activation, were both shown to be dose dependently reduced by TM24. Additional animal studies by the
same researchers using streptozotocin-induced diabetic rats supported these findings, indicating that TM is an
effective TGR5 antagonist24. In the present study, we demonstrate and confirm that TM functions as an antagonist
of the TGR5 receptor to attenuate the hyperthermia mediated by MDMA. Additionally, the D2-inhibitor IOP
significantly attenuated MDMA-mediated hyperthermic response. IOP was first shown to inhibit D2 activity and
the enzymatic conversion of T4 to T3 by Larsen et al.25. T3 has been demonstrated to increase UCP1 and UCP3
mRNA expression in BAT and skeletal muscle, respectively39,40. TGR5 receptor activation facilitates cAMP production that ultimately leads to an increase of D2 production14. The attenuated MDMA-mediated hyperthermic
response seen after D2 inhibition is consistent with previous studies from our laboratory, demonstrating a role for
thyroid hormone in the hyperthermia mediated by MDMA6.
This study suggests that the resident gut flora influences the physiological response of their host to the challenge of MDMA. The nature of this influence, and the specific members of the resident microbial community
responsible, remains to be discerned, but clearly merits further consideration. Identifying mechanisms by which
the microbiota modulate hyperthermic responses provides alternative strategies to dissect this and other complex
regulatory pathologic processes. The fact that MDMA changed the composition of the gut microbiota, coupled
with the observation that altering the gut microbiota with antibiotics modified the thermogenic response to
MDMA in the rodent model, suggests a potential relationship between human gut microbiota and body temperature regulation of relevance to our understanding of MDMA-induced pathological thermogenesis in humans.
The hyperthermia mediated by sympathomimetic agents such as MDMA involves both peripheral and central
mechanisms. The communication between the gut-brain-axis is complex and involves many of the same neurotransmitters that are targets for the pharmacological and toxicological actions of MDMA. For example, serotonin
and norepinephrine play key roles in regulating the communication between gut-brain-axis. Subsequently, an
association has been made between intestinal bacteria and the pathophysiology of CNS disorders such as autism,
depression and substance-use disorders (for a review, see41). In the present study, we did not examine the potential link between the gut-brain-axis and studies in this area are therefore warranted.
This present study was optimized to provide for a consistent pathological response to afford greater precision
to evaluate the potential of individual components (such as the composition of the gut microbiota) to enhance
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Figure 7. Effect of triamterene pretreatment on MDMA-induced hyperthermia. (A) The effects of triamterene
pretreatment 30 minutes prior to MDMA on core body temperature over a 90-minute time interval. [Each
value is the mean ± SEM (n = 6). * indicates significantly different between treatment groups (p < 0.05)].
(B) Temperature Area Under the Curve (TAUC) following MDMA treatment 30 minutes after triamterene
pretreatment. Each value is the mean ± SEM (n = 6). * indicates significantly different between treatment
groups (p < 0.05). (C) Max Change in Temperature (ΔTmax) following treatment of MDMA 30 minutes prior
to triamterene pretreatment. Each value is the mean ± SEM (n = 6). ** indicates significantly different between
treatment groups (p < 0.01).
MDMA-induced thermogenesis. To this end, we used a 20 mg/kg dose of MDMA. This is the standard dose that
our lab has used to induce MDA induced hyperthermia6. Additionally, toxicity studies with MDMA typically use
a dosage range of 10 to 80 mg/kg (for a review, see42). Ambient temperature has been shown to influence the thermogenic response to amphetamines4,43,44. O’Shea et al.45 demonstrated that rats treated with MDMA in environmental temperatures of 30 °C or higher became hyperthermic. However, if the ambient temperature is reduced to
20–22 °C, MDMA mediates a hypothermic response46. In present study, we maintained an ambient temperature
24–26 °C. Finally, we had previously demonstrated that the amount of fat in the diet further enhanced the thermogenic response to MDMA47. We therefore fed the animals a 10% fat diet.
Intriguingly, this study found the presence of a Proteus population of sufficient relative number to obscure colony counting, but only in non-ABX animals treated with MDMA. This indicated that MDMA itself either directly
or indirectly stimulates rapid alterations in the composition of the resident bacterial population of the cecum.
This suggests the possibility that the repeated use of MDMA and similar compounds may result in long-term
alterations in the composition of resident intestinal bacterial populations. This possibility and its potential consequences also merit further consideration.

Methods
Animals.

Male Sprague-Dawley rats (284.6 ± 2.4 g, Envigo, Indianapolis, IN) were used. Animals were
housed one per cage (21.0 × 41.9 × 20.3 cm3), maintained on a 12:12 h light/dark schedule, and provided access
to food and water ad libitum. Animals were sustained on a minimum 10% fat diet and housed in a room kept at
24–26 °C in order to maximize thermogenic responses47,48. Animal maintenance and research were conducted in
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Figure 8. Effects of IOP pretreatment on MDMA-induced hyperthermia. (A) The effects of IOP pretreatment
each day for 7 days and 30 minutes prior to MDMA on core body temperature over a 90-minute time interval.
Each value is the mean ± SEM (n = 6). * indicates significantly different between treatment groups (p < 0.05).
(B) Temperature Area Under the Curve (TAUC) following MDMA treatment 30 minutes after iopanoic acid
pretreatment. Each value is the mean ± SEM (n = 6). ** indicates significantly different between treatment
groups (p < 0.01). (C) Max Change in Temperature (ΔTmax) following treatment of MDMA 30 minutes after
iopanoic acid pretreatment. Each value is the mean ± SEM (n = 6). *** indicates significantly different between
treatment groups (p < 0.001).
accordance with the eighth edition of the Guide for the Care and Use of Laboratory Animals as adopted and circulated by the National Institutes of Health, and protocols were approved by the Bowling Green State University
Animal Care and Use Committee. All animals were allowed to acclimate to the facility for one week prior to the
start of any treatments.
Drugs and chemicals. Racemic MDMA was donated by Dr. Mathew Banks of Virginia Commonwealth
University (Richmond, VA) in the HCl salt form. Triamterene (TM) in salt form was obtained from Cayman
Chemicals (Ann Arbor, MI), and iopanoic acid (IOP) in salt form was obtained from Fisher Scientific (Waltham,
MA). All other chemicals and reagents were obtained from Sigma Chemical (St. Louis, MO). MDMA was diluted
in normal saline (NS), and TM and IOP in dimethylsulfoxide (DMSO).

ABX Study Design. Animals were randomly assigned to four treatment groups (n = 6): H2O saline, ABX
saline, H2O MDMA, and ABX MDMA. Antibiotics were administered via the drinking water for fourteen days in
accordance with the methods described in the study by Kiraly et al.26. Antibiotic doses were: Neomycin 2 mg/mL,
Vancomycin 0.2 mg/mL, and Bacitracin 0.5 mg/mL. Fluid intake was measured daily, and body weight was measured every five days. On the fourteenth day, animals were injected subcutaneously with either saline or MDMA
(20 mg/kg). Temperatures were taken rectally just prior to treatment (baseline) and every 30 min for an hour
post-treatment using a Physiotemp Thermalert TH-8 termocouple (Physitemp Instruments, Clifton, NJ) attached
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Target name Forward primer (5′-3′)

Reverse primer (5′-3′)

Beta-actin

CAACCTTCTTGCAGCTCCTC

TTCTGACCCATACCCACCAT

UCP-1

ATCACCTTCCCGCTGGAC

GGCAGACCGCTGTAGAGTTTC

UCP-3

TGGTGAAGGTCCGATTTCAAG

CGTTTCTTGTGATGTTGGGC

TGR-5

CTGGCCCTGGCAAGCCTCAT

CTGCCATGTAGCGCTCCCCGT

EubF-16S

TCCTACGGGAGGCAGCAGT

GGACTACCAGGGTATCTAATCCTGTT

Table 1. Primers used for quantitative PCR reactions.

to a RET-2 rectal probe. The animals were then euthanized by carbon dioxide asphyxiation and BAT, SKM, and
cecum were dissected out for qPCR analysis and for bacterial count (cecum only), UCP 1&3 and TGR5 quantification (BAT and SKM only). To rule out the systemic effects of the antibiotics, six animals were injected intraperitoneally with 1.67 mg/kg vancomycin, 20 mg/kg neomycin, and 293 U/kg bacitracin in PBS26 thirty minutes
before the administration of MDMA (20 mg/kg). Temperatures were recorded just prior to antibiotic administration (baseline) and every 30 minutes for an hour post-treatment of MDMA.

RNA isolation and qRT-PCR.

SKM and BAT were collected and preserved at −80 °C. Total RNA was isolated after homogenizing the tissues using PureZOL RNA Isolation reagent (Biorad). The concentration and
quality of the RNA was determined using a NanoDrop Spectrophotometer (Thermo) and by 1% agarose gel
electrophoresis, respectively. cDNA was synthesized from 200 ng of total RNA using the iScript Select cDNA
Synthesis Kit (Biorad). Single-plex real-time quantitative PCR was carried out in CFX Connect Real-Time PCR
Detection System (Biorad) using iTaq universal SYBR Green supermix (Biorad) with the following parameters: 3 min at 95 °C; 40 cycles of 95 °C for 10 s, 52–58 °C for 30 s, 68 °C, 10 s; and graded heating to 95 °C to generate
melt peak curve. Quantification cycle (Cq) values for all the genes within all four groups were compared and
analyzed by using the ∆∆C(t) method26. All the primer pairs used for the analysis of UCP1, UCP3, TGR5 and
actin are shown in Table 1.

™

™

qPCR for cecal bacteria.

®

™

200 mg of frozen cecal samples from each animal were ground in liquid nitrogen
and bacterial DNA was extracted using Puregene Blood Core Kit B(Qiagen, CA) according to the manufacturer’s instructions. The concentration and quality of the DNA was assessed using NanoDrop (Thermo Fisher
Scientific, PA). Equal volumes of 100 µl of DNA samples from each individual were pooled together into one sample for each treatment and was subjected to qPCR. Each qPCR reaction contained 200 ng of DNA in 20 µl reaction
volume. The qPCR reaction (iTaq Universal SYBR Green Supermix, BioRad, CA) contained the universal
eubacterial primers for 16S rRNA gene listed in Table 1. The qPCR cycle parameters were 3 min at 95 °C; 40 cycles
of 95 °C for 10 s, 55 °C for 20 s, and 68 °C, 10 s. Each qPCR reaction was run in triplicate along with reactions
without DNA (no template) as negative controls. Quantification cycles (Cq) threshold was placed above baseline
of the background noise of the fluorescence dye present in negative controls within the linear portion of the curve
and were further used for statistical analysis.

®

™

®

Agar Plate Assay and Antibiotic Screening. Cecal contents from all animals were collected in sterile tubes
and adjusted to 200 mg/ml with 4 °C phosphate buffered saline (PBS; 0.1 M, pH 7.4). The resultant cecal slurries
were homogenized and centrifuged at 400 × g for 2 minutes49. Serial 10-fold dilutions of the cecal slurry were spread
on LB agar (Miller formulation; Difco-BRL) with or without 50 µg/ml kanamycin (LBkan50), incubated at 37 °C
overnight, then manually scored for colony forming units (CFU), with the percent of kanamycin resistant (kanr)
determined by dividing the number of CFU on the LBkan50 by the number of CFU on LB, and multiplying by 100.
Isolation and Identification of Swarming Bacteria.

Swarmers were isolated from the initial LB agar
plates by subculture onto MacConkey agar (Difco-BRL), where the presence of bile salts inhibited swarming
behavior. Plates were incubated for 18 hrs at 37 °C. Resultant colonies were picked and streaked for isolation onto
fresh MacConkey agar and incubated as above. Isolated swarmer colonies were subjected to colony PCR, with
the 16S rRNA gene amplified using the primer set Eub-16S F (Table 1)50 corresponding to bp of 331 to 799 of 16S
rRNA of Escherichia coli. Sequencing of the PCR amplicons was performed at the University of Chicago DNA
sequencing and genotyping facility, Chicago, Illinois, USA. Sequences were evaluated for similarity to known
sequences in the National Center for Biotechnology Information (NCBI) nucleotide sequence database using
BLAST51.
Because the resultant rRNA sequences were identical to those of both P. mirabilis and S. enterica, the phenotype of the swarming isolate was compared to that of S. enterica, by plating on the differential medium Hektoen
enteric agar (Difco-BRL) and by the ability to swarm on LB agar.

Pharmacological inhibition of TGR5 and D2 Study Design. Animals were randomly allocated into
one of six test groups (n = 6): VEH/SAL (vehicle/saline), VEH/MDMA (MDMA only), TM/SAL (Triamterene
only), TM/MDMA, IOP/SAL (Iopanoic acid only), and IOP/MDMA. Following the methods of Li et al.24,
TM (50 mg/kg) was administered via an ip injection 30 minutes before treatment with MDMA (20 mg/kg, sc).
Animals in the IOP/SAL and IOP/MDMA groups were pretreated with IOP (50 mg/kg/day, ip) daily for seven
days, with the IOP dose size in accordance with Larsen et al.25. On day 7, animals were treated with MDMA
(20 mg/kg, sc) 30 minutes after treatment with IOP or its vehicle, and core rectal temperature was measured at
30-minute intervals for 90 minutes post-treatment.
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Statistical analysis. GraphPad InStat v.6.0 software was used to complete all statistical analyses of data.
Temperatures between treatment groups were compared using one-way ANOVA with a Student-Newman-Keuls
post-hoc test. Additionally, temperatures within a treatment group were compared using a one-way ANOVA with
a Dunnett’s post-hoc test. Maximum temperature change (ΔTmax) was calculated by comparing the maximum
increase in core temperature to the animal’s baseline temperature. An unpaired, two-tailed t-test was used to
compare the maximum temperature changes between the ABX MDMA and H2O MDMA groups. Significance
was set at the 95% confidence level (p < 0.05).
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